DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Uses of monoclonal antibody 8H9


This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides different uses of the monoclonal antibody 8H9 or its derivative.

Issue Date:
Research Org.:
Sloan-Kettering Institute for Cancer Research, New York, NY (United States)
Sponsoring Org.:
OSTI Identifier:
Patent Number(s):
Application Number:
Sloan-Kettering Institute for Cancer Research (New York, NY)
Patent Classifications (CPCs):
DOE Contract Number:  
Resource Type:
Resource Relation:
Patent File Date: 2003 Mar 06
Country of Publication:
United States

Citation Formats

Cheung, Nai-Kong V. Uses of monoclonal antibody 8H9. United States: N. p., 2010. Web.
Cheung, Nai-Kong V. Uses of monoclonal antibody 8H9. United States.
Cheung, Nai-Kong V. Tue . "Uses of monoclonal antibody 8H9". United States.
title = {Uses of monoclonal antibody 8H9},
author = {Cheung, Nai-Kong V.},
abstractNote = {This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides different uses of the monoclonal antibody 8H9 or its derivative.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2010},
month = {6}

Works referenced in this record:

Secretion of a single-gene-encoded immunoglobulin from myeloma cells.
journal, September 1993

Novel tumor target for antibody-based therapy of rhabdomyosarcoma and other pediatric solid tumors
journal, January 2000

Surface Antigen Expression and Complement Susceptibility of Differentiated Neuroblastoma Clones
journal, March 2000

Improved Gene Transfer into Human Lymphocytes Using Retroviruses with the Gibbon Ape Leukemia Virus Envelope
journal, August 1996

SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2
journal, January 1994

Complete Tumor Ablation With Iodine 131-Radiolabeled Disialoganglioside GD2-Specific Monoclonal Antibody Against Human Neuroblastoma Xenografted in Nude Mice23
journal, September 1986

Autologous stem cell transplantation for solid tumors in children
journal, January 1997

Monoclonal antibody ONS-M21 recognizes integrin α3 in gliomas and medulloblastomas
journal, December 1998

Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells
journal, July 1997

Expression of Somatostatin Receptor Subtype 2 mRNA in Human Lymphoid Cells
journal, October 1997

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
journal, September 1979

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.
journal, September 1998

Rapid selection of antigen-specific T lymphocytes by retroviral transduction
journal, July 2000

Continuous cultures of fused cells secreting antibody of predefined specificity
journal, August 1975

Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy
journal, July 1997

Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy
journal, June 1997

Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.
journal, May 1996

A Monte Carlo approach to patient-specific dosimetry
journal, September 1996

Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.
journal, May 1994

Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 Gene
journal, August 1994

Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?
journal, January 1984

Impact of chimeric immune receptor extracellular protein domains on T cell function
journal, March 1999

Tyrosine kinase chimeras for antigen-selective T-body therapy
journal, April 1998

Barriers to Drug Delivery in Solid Tumors
journal, July 1994

Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues
journal, September 2000

Detection of Prostatic Specific Membrane Antigen Messenger RNA Using Immunobead Reverse Transcriptase Polymerase Chain Reaction
journal, January 1999

The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y
journal, June 1991

Common Musculoskeletal Tumors of Childhood and Adolescence
journal, July 1999

Radioimmunotherapy with alpha-emitting nuclides
journal, September 1998

journal, August 1997

Rapid Death of Adoptively Transferred T Cells in Acquired Immunodeficiency Syndrome
journal, March 1999

3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.
journal, June 1998

Detection of (11; 22)(q24;q12) Translocation-Bearing Cells in Peripheral Blood Progenitor Cells of Patients With Ewing's Sarcoma Family of Tumors
journal, March 1995

Mammalian expression of single chain variable region fragments dimerized by Fc regions
journal, January 1995

Single‐chain Fvs
journal, January 1995

Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation
journal, April 1994

The Diagnostic Utility of Desmin: A Study of 584 Cases and Review of the Literature
journal, March 1990

Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas
journal, November 1993

Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients
journal, January 1995

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
journal, October 1995

Role of High-Dose Chemotherapy With Hematopoietic Stem Cell Rescue in the Treatment of Metastatic or Recurrent Rhabdomyosarcoma
journal, January 2001

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes
journal, March 2003

Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma.
journal, October 1993

Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma
journal, March 1992

Anti-Tumor Activity of Human T Cells Expressing the CC49-zeta Chimeric Immune Receptor
journal, January 1999

Anti-Idiotypic Antibody as the Surrogate Antigen for Cloning scFv and its Fusion Proteins
journal, December 2002

Single-chain antigen-binding proteins
journal, October 1988

Human Glioma-Specific Antigens Detected by Monoclonal Antibodies
journal, January 1992

Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor.
journal, February 1997

Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes
journal, May 2004

Expression of single-chain Fv-Fc fusions in Pichia pastoris
journal, May 2001

Disialoganglioside GD2 and a novel tumor antigen: Potential targets for immunotherapy of desmoplastic small round cell tumor
journal, October 2002

Clinical Applications of CD34 + Peripheral Blood Progenitor Cells (PBPC)
journal, March 2000

Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy
journal, January 1999

Autologous stem cell transplantation for high-risk pediatric solid tumors
journal, September 1999

An optimized method for cell-based phage display panning
journal, March 1997

Efficient Discrimination between Different Densities of Target Antigen by Tetracycline-Regulatable T Bodies
journal, March 1999

Factors Regulating the Cytotoxic Activity of the Human Natural Killer Cell Line, NK-92
journal, June 2001

A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice.
journal, September 1994

Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial
journal, February 1996

Radionuclide photon dose kernels for internal emitter dosimetry
journal, May 1996

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma
journal, January 1995

A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody.
journal, July 1986

Multimodality Diagnostics and Megatherapy in Poor Prognosis Ewing's Tumor Patients
journal, October 1999

Radiotherapy and High-Dose Chemotherapy in Advanced Ewing's Tumors
journal, October 1999

T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients
journal, February 1996

CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: Implications for cellular immunotherapy of CD20+ malignancy
journal, August 1998

Immunomagnetic Purging of Ewing’s Sarcoma From Blood and Bone Marrow: Quantitation by Real-Time Polymerase Chain Reaction
journal, August 2001

Intra-abdominal desmoplastic small cell tumor: A light microscopic, immunocytochemical, ultrastructural, and flow cytometric study
journal, August 1993

Expression of HER2/ erb B-2 Correlates With Survival in Osteosarcoma
journal, September 1999

New monoclonal antibodies specific for human sarcomas
journal, July 1986

Effect of glycosylation on antibody function: implications for genetic engineering
journal, January 1997

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
journal, October 1997

High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors
journal, December 1997

Targeting of GD2-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes
journal, January 2001

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
journal, September 1987

Immunocytokines: A Promising Approach to Cancer Immunotherapy
journal, December 1998

Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition
journal, June 1997

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.
journal, March 1994

Man-made antibodies
journal, January 1991

Monoclonal antibody against ependymoma-derived cell line
journal, January 1992

Reassessment of patient response to monoclonal antibody 3F8.
journal, April 1992

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
journal, November 1979

Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors
journal, October 1996

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.
journal, August 1988

Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing’s sarcoma
journal, November 1998

In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion protein
journal, February 1996

An alternating selection strategy for cloning phage display antibodies
journal, August 1999

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
journal, January 1993

Biotechnological and gene therapeutic strategies in cancer treatment
journal, June 1995

High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes.
journal, August 1995

Comparison of three different methods for radiolabelling human activated T lymphocytes
journal, May 1997

Antigen-dependent CD28 Signaling Selectively Enhances Survival and Proliferation in Genetically Modified Activated Human Primary T Lymphocytes
journal, August 1998

Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus.
journal, January 1991

Superantigen-staphylococal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells
journal, March 1995

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor
journal, January 2002

Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.
journal, April 1988

Targeting Tumor Specific Translocations in Sarcomas in Pediatric Patients for Immunotherapy
journal, January 2000

Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumours
journal, August 1999

Disialoganglioside GD2 anti-idiotypic monoclonal antibodies
journal, May 1993

Expression of CD44 splice variants in human primary brain tumors
journal, December 1995

In vivo tracking of tumor-specific T cells
journal, April 2001

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
journal, August 1970

Physical barriers to drug delivery in tumors
journal, February 1993

Radioimmunolocalisation of human brain tumours: Biodistribution of radiolabelled monoclonal antibody UJ13A
journal, October 1986

Expression of 300-kilodalton intermediate filament-associated protein distinguishes human glioma cells from normal astrocytes.
journal, September 1993

Radioimmunotherapy: recent results and future directions.
journal, April 1996

Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92
journal, August 2001

Radioimmunotargeting of Human Rhabdomyosarcoma Using Monoclonal Antibody 8H9
journal, October 2005

Diagnostic imaging of human neuroblastoma with radiolabeled antibody.
journal, November 1986

Intra-abdominal Desmoplastic Small Round-Cell Tumor: Report of 19 Cases of a Distinctive Type of High-Grade Polyphenotypic Malignancy Affecting Young Individuals
journal, January 1991

A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2
journal, May 1991

Adoptive cellular immunotherapy for EBV lymphoproliferative diseases
journal, June 1997

Intraparenchymal and Intratumoral Interstitial Infusion of Anti-Glioma Monoclonal Antibody 8h9
journal, December 2008

Functional expression of chimeric receptor genes in human T cells
journal, February 2001

Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors
journal, February 1999

Making Antibodies by Phage Display Technology
journal, April 1994

Phage Library-derived Human Anti-TETA and Anti-DOTA ScFv for Pretargeting RIT
journal, February 1999

Cloning of the Human Sodium Iodide Symporter
journal, September 1996

A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a
journal, May 1992

Intergroup Rhabdomyosarcoma Study: Update for Pathologists
journal, November 1998

Progress in the Diagnosis and Treatment of Rhabdomyosarcoma and Related Soft Tissue Sarcomas
journal, January 2000

Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?
journal, August 1997

Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers
journal, February 1996

Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity
journal, February 1999

Applications of monoclonal antibodies in clinical oncology
journal, December 1994

The Third Intergroup Rhabdomyosarcoma Study.
journal, March 1995

A humanized antibody that binds to the interleukin 2 receptor.
journal, December 1989

Title>Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells
journal, November 1997

The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
journal, November 1997

Occurrence of ganglioside GD3 in neoplastic astrocytes
journal, March 1999

A new class of antigen-specific killer cells
journal, January 1997

Monoclonal antibody-based therapy for neuroblastoma
journal, December 2000

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
journal, August 1993